Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2910)
All Articles published online
|
Jun 28, 2008 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Al-Moundhri MS, Al-Shukaili A, Al-Nabhani M, Al-Bahrani B, Burney I, Rizivi A, Ganguly S. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J Gastroenterol 2008; 14(24): 3879-3883 [PMID: 18609713 DOI: 10.3748/wjg.14.3879] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3879.htm |
| Number | Citing Articles |
| 1 |
Roberto Nersita, Antonio Matrone, Michele Klain, Francesco Scavuzzo, Gabriella Vitolo, Ciro Abbondanza, Maria V. Carlino, Veronica Giacco, Giovanni Amato, Carlo Carella. Decreased serum vascular endothelial growth factor‐D levels in metastatic patients with differentiated thyroid carcinoma. Clinical Endocrinology 2012; 76(1): 142 doi: 10.1111/j.1365-2265.2011.04183.x
|
| 2 |
Chenghai Li, Bin Liu, Zonghan Dai, Yunxia Tao. Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC). Cancer Biology & Therapy 2011; 12(10): 872 doi: 10.4161/cbt.12.10.17672
|
| 3 |
Sedef Hande AKTAŞ, Hakan AKBULUT, Ozan YAZICI, Nurullah ZENGİN, Halime Nalan AKGÜN, Zeki ÜSTÜNER, Fikri İÇLİ. A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin1 predicts survival in patients with advanced gastric cancer. TURKISH JOURNAL OF MEDICAL SCIENCES 2017; 47: 399 doi: 10.3906/sag-1509-80
|
| 4 |
YOSHIKO AOYAGI, HISAE IINUMA, ATSUSHI HORIUCHI, RYU SHIMADA, TOSHIAKI WATANABE. Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6. Oncology Letters 2010; 1(2): 253 doi: 10.3892/ol_00000045
|
| 5 |
Jennifer A Rusiecki, Maryam Al-Nabhani, Letizia Tarantini, Ligong Chen, Andrea Baccarelli, Mansour S Al-Moundhri. Global DNA Methylation and Tumor Suppressor Gene Promoter Methylation and Gastric Cancer Risk in an Omani Arab Population. Epigenomics 2011; 3(4): 417 doi: 10.2217/epi.11.65
|
| 6 |
Ewen Legg. Regorafenib in Advanced and Refractory Gastrointestinal Cancers. European Medical Journal 2016; : 21 doi: 10.33590/emj/10311556
|
| 7 |
Min-Chao Liu, Lei Jiang, Hai-Jie Hong, Ze-Wu Meng, Qiang Du, Liang-Yi Zhou, Fei-Fei She, Yan-Ling Chen. Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma. Tumor Biology 2015; 36(8): 6305 doi: 10.1007/s13277-015-3316-3
|
| 8 |
Brahim El Bali, Amani Direm, Mohammed Lachkar, Diana Díaz-García, Santiago Gómez-Ruiz, Hassan Dihazi. In vitro and in silico studies of a di-copper cyclam complex for anticancer application: functionalization, cytotoxicity, ADMET profile and molecular docking as a VEGFR1 inhibitor. Transition Metal Chemistry 2024; doi: 10.1007/s11243-024-00597-4
|
| 9 |
Shogo Kikuchi, Yuki Obata, Kiyoko Yagyu, Yingsong Lin, Toshifusa Nakajima, Osamu Kobayashi, Masahiro Kikuichi, Ryo Ushijima, Michiko Kurosawa, Junko Ueda. Reduced serum vascular endothelial growth factor receptor‐2 (sVEGFR‐2) and sVEGFR‐1 levels in gastric cancer patients. Cancer Science 2011; 102(4): 866 doi: 10.1111/j.1349-7006.2011.01860.x
|
| 10 |
Ewen D. Legg. Regorafenib in Advanced and Refractory Gastrointestinal Cancers. EMJ Gastroenterology 2016; : 18 doi: 10.33590/emj/10313749
|
| 11 |
Tian‐Bao WANG, Jin WANG, Xiu‐Qing WEI, Bo WEI, Wen‐Guang DONG. Serum vascular endothelial growth factor‐C combined with multi‐detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer. Asia-Pacific Journal of Clinical Oncology 2012; 8(2): 180 doi: 10.1111/j.1743-7563.2011.01490.x
|
| 12 |
Fa Fang, Jie Gao, Xing Bi, Feng Han, Hai-jiang Wang. Effect and clinical significance of fast-track surgery combined with laparoscopic radical gastrectomy on the plasma level of vascular endothelial growth factor in gastric antrum cancer. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-1699-2
|
| 13 |
Masaki Hirose, Akiko Matsumuro, Toru Arai, Chikatoshi Sugimoto, Masanori Akira, Masanori Kitaichi, Lisa R. Young, Francis X. McCormack, Yoshikazu Inoue, Wei Shi. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis. PLOS ONE 2019; 14(2): e0212776 doi: 10.1371/journal.pone.0212776
|
| 14 |
Tian-Bao Wang, Zhong-Gang Chen, Xiu-Qing Wei, Bo Wei, Wen-Guang Dong. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ Journal of Surgery 2011; 81(10): 694 doi: 10.1111/j.1445-2197.2010.05539.x
|
| 15 |
Aydan Eroğlu. Serum levels of vascular endothelial growth factor in gastric cancer patients. Journal of Surgical Oncology 2011; 104(2): 222 doi: 10.1002/jso.21900
|
| 16 |
H. Y. Seo, J. M. Park, K. H. Park, S. J. Kim, S. C. Oh, B. S. Kim, Y. H. Kim, J. S. Kim. Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients. Japanese Journal of Clinical Oncology 2010; 40(12): 1147 doi: 10.1093/jjco/hyq111
|
| 17 |
Theodoros D. Tsirlis, Alkiviadis Kostakis, George Papastratis, Kiriaki Masselou, Ioannis Vlachos, Antonios Papachristodoulou, Nikolaos I. Nikiteas. Predictive significance of preoperative serum VEGF‐C and VEGF‐D, independently and combined with Ca19‐9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. Journal of Surgical Oncology 2010; 102(6): 699 doi: 10.1002/jso.21677
|
| 18 |
Emin Avsar. Inhibitors of Molecular Chaperones as Therapeutic Agents. 2013; : 336 doi: 10.1039/9781849739689-00336
|
| 19 |
P.I. Imoukhuede, Aleksander S. Popel. Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. Experimental Cell Research 2011; 317(7): 955 doi: 10.1016/j.yexcr.2010.12.014
|
| 20 |
M. Moehler, A. Mueller, J.T. Hartmann, M.P. Ebert, S.E. Al-Batran, P. Reimer, M. Weihrauch, F. Lordick, T. Trarbach, S. Biesterfeld, M. Kabisch, D. Wachtlin, P.R. Galle. An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer. European Journal of Cancer 2011; 47(10): 1511 doi: 10.1016/j.ejca.2011.04.006
|
| 21 |
Antony M. Latham, Carmen Molina-París, Shervanthi Homer-Vanniasinkam, Sreenivasan Ponnambalam. An integrative model for vascular endothelial growth factor A as a tumour biomarker. Integrative Biology 2010; 2(9): 397 doi: 10.1039/c0ib00008f
|
| 22 |
Antonio Rueda, David Olmos, Luis Vicioso, Cristina Quero, Elena Gallego, Bella Isabel Pajares-Hachero, Marta Mendiola, María Casanova, Martina Álvarez, Mariano Provencio, Emilio Alba. Role of vascular endothelial growth factor C in classical Hodgkin lymphoma. Leukemia & Lymphoma 2015; 56(5): 1286 doi: 10.3109/10428194.2014.952227
|
| 23 |
Wen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, Wei-Chih Liao, Chia-Hung Chen, Hung-Jen Chen, Chih-Yen Tu, Te-Chun Hsia. Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study. Cancers 2023; 15(3): 642 doi: 10.3390/cancers15030642
|
| 24 |
Francisco Botelho, Francisco Pina, Nuno Lunet. VEGF and prostatic cancer: a systematic review. European Journal of Cancer Prevention 2010; 19(5): 385 doi: 10.1097/CEJ.0b013e32833b48e1
|
| 25 |
Hanna Sallinen, Tommi Heikura, Jonna Koponen, Veli-Matti Kosma, Seppo Heinonen, Seppo Ylä-Herttuala, Maarit Anttila. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-696
|
| 26 |
Jianghong Wu, Xiaowen Liu, Yanong Wang. Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer. BMC Clinical Pathology 2013; 13(1) doi: 10.1186/1472-6890-13-15
|
| 27 |
Isotta Chimenti, Rachel Ruckdeschel Smith, Tao-Sheng Li, Gary Gerstenblith, Elisa Messina, Alessandro Giacomello, Eduardo Marbán. Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice. Circulation Research 2010; 106(5): 971 doi: 10.1161/CIRCRESAHA.109.210682
|
| 28 |
Hua Zhu, Chuanke Zhao, Fei Liu, Lixin Wang, Junnan Feng, Chengchao Shou, Zhi Yang. 125I–F56 Peptide as Radioanalysis Agent Targeting VEGFR1 in Mice Xenografted with Human Gastric Tumor. ACS Medicinal Chemistry Letters 2017; 8(2): 266 doi: 10.1021/acsmedchemlett.6b00498
|
| 29 |
Jean-Louis Formento, Marie-Christine Etienne-Grimaldi, Mireille Francoual, Gilles Pagès, Cercina Onesto, Patricia Formento, Emmanuel Chamorey, Olivier Dassonville, Gilles Poissonnet, Gérard Milano.
Influence of the
VEGF-A
936C>T Germinal Polymorphism on Tumoral VEGF Expression in Head and Neck Cancer
. Pharmacogenomics 2009; 10(8): 1277 doi: 10.2217/pgs.09.54
|
| 30 |
Barbara Vizio, Anna Novarino, Alice Giacobino, Carmen Cristiano, Adriana Prati, Gabriele Brondino, Libero Ciuffreda, Graziella Bellone. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. Cancer Science 2010; 101(11): 2448 doi: 10.1111/j.1349-7006.2010.01692.x
|
| 31 |
Ghazaleh Khalili-Tanha, Nima Khalili-Tanha, Arian Karimi Rouzbahani, Ramisa Mahdieh, Kimia Jasemi, Rosa Ghaderi, Fatemeh Khojasteh Leylakoohi, Elnaz Ghorbani, Majid Khazaei, Seyed Mahdi Hassanian, Ibrahim Saeed Gataa, Gordon A Ferns, Elham Nazari, Amir Avan. Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers. Translational Research 2024; 274: 35 doi: 10.1016/j.trsl.2024.09.001
|